| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bffe926681f73580c63f8bbeff581d9f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-47 |
| filingDate |
2019-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066d1ab69cdd7fa357e478b12db2c6a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c7d1cfea01269e5ce07eb34291d0a04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc8372252f5ee0b9d3742c3da35f9cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4be5d426ed7a878e28c07019f7628e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4502dea5191d04d34f33b4132bf182ba |
| publicationDate |
2020-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020038434-A1 |
| titleOfInvention |
Pharmaceutical composition of 2-aminopyrimidine compounds |
| abstract |
Disclosed is a pharmaceutical composition of 2-aminopyrimidine compounds or pharmaceutically acceptable salts thereof. Specifically provided are a pharmaceutical composition comprising N-((5-((5-chlorine-4-((naphthalen-1-yl)amino))pyrimidin-2-yl)amino)-2-((N-methyl-N-dimethylaminoethyl)amino)-4-methoxy phenyl)acrylamide or pharmaceutically acceptable salts thereof. Also provided is a method for preparing the pharmaceutical composition. |
| priorityDate |
2018-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |